A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
PHASE3
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Ev...
Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening
N/A
The goal of this observational study is to learn the efficacy, cosmetic eff...
Status
Completed
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2018-01-01
Trial ID
NCT07229859
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
PHASE1
This phase I trial studies the side effects and best dose of lapatinib when...